Easily Identify Key Oncology Biomarkers

Archer DX offers easy to use, accurate and actionable NGS detection kits that helps you fight against cancer.

Available In: United Arab Emirates, Saudi Arabia, Qatar, Bahrain, Kuwait, Oman, Iraq…

Lebanon, Yemen, Egypt, Algeria, Morocco, Tunisia and Pakistan.

Show more

Don’t see your country and want to introduce this product in your region? Contact us here.
View products:
Solid Tumor Research
ArcherDx Solid Tumor research panels offer a sensitive targeted sequencing approach for biomarker detection from both liquid and tissue biopsies. This approach leverages DNA, RNA or ctDNA input types for sensitive characterization of all variant types from low-input clinical research samples. The different solid tumor based panels from ArcherDx includes:

RNA Input

DNA Input

ctDNA

Blood Cancer Research
ArcherDx blood Cancer research tests detect various driver mutations in hematologic malignancies, such as myeloid and lymphoid diseases, by targeted next-generation sequencing (NGS). This approach combines FusionPlex® and VariantPlex® panels to characterize gene fusions, point mutations, copy number variations (CNVs) and other variant types from a single sample. The different blood cancer based panels from ArcherDx includes:

RNA Input

DNA Input

Custom Panels

ArcherDx also allows the customer to design custom next-generation sequencing (NGS) panels for RNA, DNA, or ctDNA input to meet the needs of every lab.

Anchored Multiplex PCR (AMP™)

AMP is a powerful method for amplifying minuscule amount of nucleic acids. Combined with Next Generation sequencing, AMP allows you to detect gene rearrangements (gene fusions) without you needing to know fusion partners from small and poor quantities of nucleic acid.

Molecular Barcodes (MBCS)

Adapters ligated to molecules before amplification carry MBCs that enable unique molecule counting and powerful error correction for confident mutation calling. MBCs help sequence analysis software’s to filter out duplicate reads and PCR errors to report unique reads.

NRTK Fusion Detection

NTRK fusions with known and unknown fusion partners that are notoriously difficult to detect are critical events in cancer biology. FusionPlex® NGS research assays provide sensitive NTRK fusion detection without prior knowledge of fusion.

Partner Details
Categories:
Life Sciences
Tags:

Complementary Partners